In 2023, Tim Bertram, Ph.D. earned $1.46M in total compensation at ProKidney Corp., including $544.11K salary and $194.34K bonus. Led ProKidney Corp. as CEO for 2 years.
Compensation History
Annual executive compensation data for Tim Bertram, Ph.D., including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.46M
Salary
$544.11K
Bonus
$194.34K
Other
$720.79K
Salary
$544.11KBoard Justification
The compensation philosophy is designed to attract, retain, and motivate senior management leaders capable of advancing the company's mission and strategy, rewarding them in alignment with financial performance and equity ownership.
Bonus
$194.34KBoard Justification
The bonus of $194,343 represents the cash bonus earned by Dr. Bertram pursuant to the Non-Equity Incentive Compensation Plan for performance in 2023, which was based on a corporate goal achievement of 59.8%.
Other Compensation
$720.79KBoard Justification
Other compensation includes $620,000 in salary continuation accrued in connection with termination, $16,880 in health plan continuation, $12,912 in matching contributions to the 401(k) plan, a pension allowance of $16,847, earned but unused vacation of $53,654 paid upon termination, and insurance premiums for various policies.
Restricted Stock
Board Justification
No stock awards vested in 2023 as Dr. Bertram's employment was terminated effective November 15, 2023, and he did not receive any stock awards that vested during that year.
Performance Metrics
The performance metrics for determining Dr. Bertram's compensation included achieving corporate goals set by the Talent and Compensation Committee.
Tim Bertram, Ph.D.
Ex-CEO of ProKidney Corp.
Education
Ph.D. in a relevant field from a recognized institution.
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
Born
January 1, 1980 - 45 years ago
CEO of ProKidney Corp. for
2 years 4 months (Jun 2021 - Nov 2023)
Previous Experience
Various roles in the biotech industry, including leadership positions in clinical development and operations.
Other ProKidney Corp. CEOs
Holdings
Track Tim Bertram, Ph.D.'s stock holdings and portfolio value over time.
Insider Trading
Tim Bertram, Ph.D.'s recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Tim Bertram, Ph.D. with competitor CEOs and industry peers.